Target intelligence / Profile preview

Novel transcript (no established human gene or protein name)

Molecular classification
Other (lncRNA, non-coding RNA)
01

Overview

ENSG00000288700 refers to a novel RNA transcript identified from large-scale transcriptome analysis, likely representing a long non-coding RNA (lncRNA). It has no established protein-coding function, nor is it well-characterized regarding biological role or disease association. Some studies have reported its altered expression in the context of peripheral blood from Parkinson’s disease patients, suggesting possible—but unproven—utility as a biomarker, but it is not an established therapeutic target nor classified in any major molecular target family[1][3][5]. The name "novel transcrpt" is non-standard and appears to be a typo. Summary: ENSG00000288700 ("novel transcript") is a poorly characterized, likely non-coding RNA with no evidence of being a therapeutic target, and carries an incorrect and non-standard designation. Existing information is insufficient for standard molecular and clinical annotation, beyond its preliminary transcriptomic identification[1][3][5].

Other names
RP11-875O11.5-001RP11-875O11.5Novel transcript
02

Biological functions

Unknown or other (function not established; possibly tissue-specific expression and potential regulatory roles, as many lncRNAs are suggested to be involved in gene expression regulation, but no direct evidence for this transcript)
03

Disease associations

Other (no direct evidence, but related lncRNAs may be explored as biomarkers in neurodegenerative disease, such as Parkinson's disease)
04

Biomarkers

Potential, not established (as novel lncRNAs, some may be studied as experimental biomarkers; ENSG00000288700 is suggested as a candidate from transcriptome studies in Parkinson's disease, but not validated)

Beyond the preview

Go deeper on Novel transcript (no established human gene or protein name).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript (no established human gene or protein name).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call